Smith Hunter Cinsider trades
In SEC Form 4 filings, Smith Hunter C is listed as Chief Financial Officer of Rhythm Pharmaceuticals, Inc. (RYTM). In the last 90 days, Smith Hunter C sold $6.62M of Rhythm Pharmaceuticals, Inc. (RYTM) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RYTMRhythm Pharmaceuticals, Inc. | Chief Financial Officer | 5 | Sep 1 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-01
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RYTMRhythm Pharmaceuticals, Inc. | Aug 31 | Sep 1 | M | 57,187 | $25.79 | $1,474,853 | 176,798 | Yes | Form 4 |
| RYTMRhythm Pharmaceuticals, Inc. | Aug 31 | Sep 1 | S | 23,072 | $104.59 | Sale −$2,413,034 | 153,726 | Yes | Form 4 |
| RYTMRhythm Pharmaceuticals, Inc. | Aug 31 | Sep 1 | S | 11,514 | $105.37 | Sale −$1,213,232 | 142,212 | Yes | Form 4 |
| RYTMRhythm Pharmaceuticals, Inc. | Aug 31 | Sep 1 | S | 28,188 | $106.20 | Sale −$2,993,647 | 114,024 | Yes | Form 4 |
| RYTMRhythm Pharmaceuticals, Inc. | Aug 31 | Sep 1 | M · derivative | 57,187 | $25.79 | $1,474,853 | 3,813 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.